Extendicare Inc. (TSE:EXE - Get Free Report) announced a monthly dividend on Wednesday, April 30th, TickerTech Dividends reports. Stockholders of record on Thursday, May 15th will be paid a dividend of 0.042 per share on Thursday, May 15th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 3.48%. The ex-dividend date of this dividend is Wednesday, April 30th. This is a 5.0% increase from Extendicare's previous monthly dividend of $0.04.
Extendicare Price Performance
Shares of TSE EXE traded up C$0.44 during mid-day trading on Friday, reaching C$14.50. The company had a trading volume of 215,593 shares, compared to its average volume of 188,659. Extendicare has a 1-year low of C$7.10 and a 1-year high of C$14.55. The stock has a market cap of C$1.21 billion, a PE ratio of 18.49 and a beta of 1.26. The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02. The company has a 50-day moving average price of C$13.04 and a two-hundred day moving average price of C$11.20.
Analyst Ratings Changes
Several research analysts have commented on EXE shares. TD Securities raised their target price on shares of Extendicare from C$10.50 to C$13.00 and gave the stock a "hold" rating in a report on Monday, March 3rd. BMO Capital Markets lifted their price objective on shares of Extendicare from C$11.00 to C$13.50 in a research report on Monday, March 3rd. Finally, Cormark upgraded Extendicare to a "moderate buy" rating in a report on Wednesday, February 19th.
Read Our Latest Stock Analysis on EXE
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Read More
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
